SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-21-000035
Filing Date
2021-02-04
Accepted
2021-02-04 21:15:57
Documents
1
Period of Report
2021-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161249134328472.html 4  
1 FORM 4 wf-form4_161249134328472.xml 4 5684
  Complete submission text file 0001479290-21-000035.txt   7036
Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE TN 37203 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO CA 94080
Business Address
Schilke Tobin (Reporting) CIK: 0001678984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 21593106